This transcript has been edited for clarity.
Since oral contraceptives first became available, there have been concerns that antibiotics might interfere with their efficacy. However, a review of studies examining pharmacokinetic outcomes and suppression of ovulation by Centers for Disease Control and Prevention (CDC) authors concludes that common non-enzyme–inducing antibiotics do not impair the effectiveness of oral contraceptives.
In a recent report published in BMJ Evidence-Based Medicine (which has received media attention), investigators reviewed thousands of spontaneous reports of suspected adverse drug reactions (ADRs) submitted to Britain's regulatory authority. These ADRs referred to unintended pregnancy while taking medications in one of three categories:
Commonly used non-enzyme–inducing antibiotics, including ampicillin, cephalosporins, tetracyclines, and metronidazole
Hepatic enzyme-inducing medications known to interact with some hormonal contraceptives, including carbamazepine, nevirapine, and rifampin
Control medications, including citalopram, ibuprofen, and zolpidem, commonly used by reproductive-age women and not known to impact efficacy of hormonal contraceptives
ADRs involving control medications included nine pregnancies reported per 100,000 ADRs. The rates were 62 and 119, respectively, for ADRs involving non-enzyme–inducing antibiotics and enzyme-inducing medications.
The authors indicate that the sevenfold higher rate of reported unintended pregnancies with antibiotics "...constitutes a signal of possible drug-drug interaction."
Keep in mind, though, that this analysis is entirely based on spontaneous reporting of adverse events.
COMMENTARY
Antibiotics and Oral Contraceptives: Should We Worry?
Andrew M. Kaunitz, MD
DisclosuresSeptember 18, 2020
This transcript has been edited for clarity.
Since oral contraceptives first became available, there have been concerns that antibiotics might interfere with their efficacy. However, a review of studies examining pharmacokinetic outcomes and suppression of ovulation by Centers for Disease Control and Prevention (CDC) authors concludes that common non-enzyme–inducing antibiotics do not impair the effectiveness of oral contraceptives.
In a recent report published in BMJ Evidence-Based Medicine (which has received media attention), investigators reviewed thousands of spontaneous reports of suspected adverse drug reactions (ADRs) submitted to Britain's regulatory authority. These ADRs referred to unintended pregnancy while taking medications in one of three categories:
Commonly used non-enzyme–inducing antibiotics, including ampicillin, cephalosporins, tetracyclines, and metronidazole
Hepatic enzyme-inducing medications known to interact with some hormonal contraceptives, including carbamazepine, nevirapine, and rifampin
Control medications, including citalopram, ibuprofen, and zolpidem, commonly used by reproductive-age women and not known to impact efficacy of hormonal contraceptives
ADRs involving control medications included nine pregnancies reported per 100,000 ADRs. The rates were 62 and 119, respectively, for ADRs involving non-enzyme–inducing antibiotics and enzyme-inducing medications.
The authors indicate that the sevenfold higher rate of reported unintended pregnancies with antibiotics "...constitutes a signal of possible drug-drug interaction."
Keep in mind, though, that this analysis is entirely based on spontaneous reporting of adverse events.
Medscape Ob/Gyn © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Andrew M. Kaunitz. Antibiotics and Oral Contraceptives: Should We Worry? - Medscape - Sep 18, 2020.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Andrew M. Kaunitz, MD
Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville
Disclosure: Andrew M. Kaunitz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: AMAG Pharmaceuticals, Inc.; Merck & Co., Inc; Mithra; Pfizer Inc
Receives research grants (funds paid to University of Florida) from: Allergan, Inc.; Bayer HealthCare Pharmaceuticals; Endoceutics; Evafem; Mithra; Myovant; Medicines360
Serve(d) on the Safety Monitoring Board for: Femasys
Received royalties from: UpToDate